My only point was wait for the JA and the ending of the quiet period before complaints about no media coverage. Of course the media coverage will be miniscule while the company isn't talking. I suspect we should be hearing a lot more soon.
They are embargoed and advertisements are a waste of money at this stage as forbidden by the FDA in the way you suggest. They’d likely cause themselves serious problems with their regulators, not really a good idea.